Devyser Diagnostics AB (FRA:OL0) FCF Margin %: -0.98% (As of Mar. 2026)

What is Devyser Diagnostics AB FCF Margin %?

Devyser Diagnostics AB FRA:OL0 77 FCF Margin % is -0.98% as of Mar. 2026. GuruFocus rates FRA:OL0 with a GF Score™ of 77/100 and a GF Value™ of €14.06 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Devyser Diagnostics AB ranks worse than 68.71% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Devyser Diagnostics AB's Free Cash Flow for the three months ended in Mar. 2026 was €-0.06 Mil. Devyser Diagnostics AB's Revenue for the three months ended in Mar. 2026 was €5.74 Mil. Therefore, Devyser Diagnostics AB's FCF Margin % for the quarter that ended in Mar. 2026 was -0.98%.

As of today, Devyser Diagnostics AB's current FCF Yield % is -2.67%.

The historical rank and industry rank for Devyser Diagnostics AB's FCF Margin % or its related term are showing as below:

FRA:OL0' s FCF Margin % Range Over the Past 10 Years
Min: -60.07 Med: -25.9 Max: 8.27
Current: -14.54

During the past 9 years, the highest FCF Margin % of Devyser Diagnostics AB was 8.27%. The lowest was -60.07%. And the median was -25.90%.

FRA:OL0's FCF Margin % is ranked worse than
68.71% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.1 vs FRA:OL0: -14.54

Devyser Diagnostics AB FCF Margin % Related Terms

Devyser Diagnostics AB FCF Margin % Historical Data

* Premium members only.

The historical data trend for Devyser Diagnostics AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Devyser Diagnostics AB FCF Margin % Chart

Devyser Diagnostics AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

-27.05

-52.37

-60.07

-58.83

-24.75

Devyser Diagnostics AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
FCF Margin %	Get a 7-Day Free Trial															-46.33	-22.70	-31.73	-5.43	-0.98

FRA:OL0 vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, Devyser Diagnostics AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Devyser Diagnostics AB FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Devyser Diagnostics AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Devyser Diagnostics AB's FCF Margin % falls into.

Save Embed

77GF Score

Devyser Diagnostics AB FRA:OL0

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Devyser Diagnostics AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Devyser Diagnostics AB's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-5.697	/	23.019
	=	-24.75 %

Devyser Diagnostics AB's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-0.056	/	5.737
	=	-0.98 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -0.98% mean?

Devyser Diagnostics AB (FRA:OL0) has a FCF Margin % of -0.98% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Devyser Diagnostics AB and its competitors. According to the industry distribution chart, Devyser Diagnostics AB ranks #560 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 68.7%.

Is Devyser Diagnostics AB's FCF Margin % too high?

Devyser Diagnostics AB's current FCF Margin % is -0.98%. Based on the distribution chart, Devyser Diagnostics AB ranks #560 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Devyser Diagnostics AB has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Devyser Diagnostics AB's FCF Margin % compare to ABT and SYK?

According to the Medical Devices & Instruments industry distribution chart, Devyser Diagnostics AB ranks #560 out of 815 companies for FCF Margin %. This places Devyser Diagnostics AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Medical Devices & Instruments company?

A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Devyser Diagnostics AB and its competitors. Devyser Diagnostics AB's current FCF Margin % is -0.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Devyser Diagnostics AB stock overvalued right now?

Based on GuruFocus' analysis, Devyser Diagnostics AB (FRA:OL0) is currently considered Significantly Undervalued. The stock's GF Value™ is €14.06, compared to a current price of €7.59 — trading 46% below its estimated fair value. The current FCF Margin % is -0.98%. Devyser Diagnostics AB's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Devyser Diagnostics AB (FRA:OL0), the current FCF Margin % is -0.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Devyser Diagnostics AB (FRA:OL0) Overvalued in 2026?

Based on GuruFocus' analysis, Devyser Diagnostics AB stock appears to be undervalued. The current stock price of €7.59 is trading 46% below its estimated GF Value™ of €14.06. GuruFocus considers Devyser Diagnostics AB to be Significantly Undervalued.

Key valuation signals for FRA:OL0:

FCF Margin %: -0.98%
GF Value™: €14.06 vs. price of €7.59 (46% below fair value)
GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the FRA:OL0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Devyser Diagnostics AB Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies OSTO:BICO OSTO:PAX OSTO:CRAD B OSTO:SEDANA OSTO:EPIS B OSTO:SEZI OSTO:BACTI B OSTO:SCIB OSTO:OSSD OSTO:MNTC ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA

Other Exchanges DVYSR:Sweden

Address Branningevagen 12, Arsta, SWE, 120 54

Website https://www.devyser.com

Devyser Diagnostics AB is engaged in the development, manufacture, and sale of kits for genetic testing in routine diagnostic laboratories. The products are used for advanced genetic testing in the hereditary disease, oncology, and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.

77GF Score

Get the complete analysis for FRA:OL0

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.59

Price

€14.06

GF Value

View FRA:OL0 Analysis

See FCF Margin % data for all stocks →